Promea
Generated 5/25/2026
Executive Summary
Promea is an Indian medical-device and digital-health company leveraging AI and machine learning to create intelligent monitoring and diagnostic solutions. Founded in 2020 and based in Bengaluru, the company focuses on AI-enabled wearable and bedside devices that capture physiological data, apply predictive analytics, and deliver actionable insights to clinicians and patients. Its technology combines sensor fusion with cloud-based analytics, targeting chronic disease management and early disease detection. Currently in the commercial stage with 50–200 employees, Promea is positioning itself as a key player in the emerging AI-driven healthcare market in India. The company’s differentiated approach—integrating AI directly into hardware—sets it apart from software-only competitors, though specific revenue metrics and funding details remain undisclosed.
Upcoming Catalysts (preview)
- Q4 2026Regulatory Approval for AI-Based Cardiac Monitoring Device60% success
- Q3 2026Strategic Partnership with Major Hospital Chain in India70% success
- Q1 2027Launch of Next-Generation Wearable Predictive Analytics Platform50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)